VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated ...
Qiagen N.V. is supported by new product launches and automation initiatives poised to drive revenue growth. See why I rate ...
QIAsymphony Connect will serve as a foundation for lab workflows, enabling standardized nucleic acid extraction for clinical and translational research Introduction of the QIAGEN Discovery Platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results